Lunai Bioworks (LNAI) Capital Expenditures (2014 - 2024)
Lunai Bioworks (LNAI) posted quarterly Capital Expenditures of $23552.0 for Q2 2024, up 283.52% year-over-year from $6141.0 in Q3 2023, and up 344.88% quarter-over-quarter from $5294.0 in Q1 2024.
Lunai Bioworks (LNAI) Capital Expenditures (2014 - 2024) Analysis & Trends
Lunai Bioworks' Capital Expenditures history runs 7 years deep, the most recent figure standing at $23552.0 for Q2 2024.
- In Q2 2024, Capital Expenditures rose 283.52% year-over-year to $23552.0; the TTM figure through Mar 2026 stood at $34987.0 (changed N/A YoY), while the FY2024 annual figure was $70430.0, up 136.55% from the prior year.
- Capital Expenditures for Q2 2024 stood at $23552.0, up from $5294.0 in the prior quarter.
- The five-year high for Capital Expenditures was $376798.0 in Q2 2020, with the low at -$64724.0 in Q1 2020.
- The 4-year median for Capital Expenditures is $8431.0 (2020), against an average of $50138.6.
- Peak annual rise in Capital Expenditures reached 2382.66% in 2020, while the deepest fall reached 169.87% in 2020.
- Lunai Bioworks' Capital Expenditures stood at $10721.0 in 2020, then tumbled by 51.91% to $5156.0 in 2021, then gained by 19.1% to $6141.0 in 2023, then surged by 283.52% to $23552.0 in 2024.
- Business Quant data shows LNAI's Capital Expenditures at $23552.0 in Q2 2024, $5294.0 in Q1 2024, and $6141.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 34.68 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.26 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 251.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -73.57 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 23,552.00 |
| Jun 30, 2024 | 23,552.00 |
| Mar 31, 2024 | 5,294.00 |
| Mar 31, 2024 | 5,294.00 |
| Jun 30, 2023 | 6,141.00 |
| Jun 30, 2023 | 6,141.00 |
| Sep 30, 2021 | 5,156.00 |
| Sep 30, 2021 | 5,156.00 |
| Jun 30, 2021 | 38,171.00 |
| Jun 30, 2021 | 38,171.00 |
| Dec 31, 2020 | 10,721.00 |
| Dec 31, 2020 | 10,721.00 |
| Jun 30, 2020 | 376,798.00 |
| Jun 30, 2020 | 376,798.00 |
| Mar 31, 2020 | -64,724.00 |
| Mar 31, 2020 | -64,724.00 |
| Dec 31, 2019 | -58,745.00 |
| Dec 31, 2019 | -58,745.00 |
| Sep 30, 2019 | -68,866.00 |
| Sep 30, 2019 | -68,866.00 |